Daxor to Participate in the Maxim Group 2021 Emerging Growth Virtual Conference
March 16, 2021 08:30 ET
|
Daxor Corporation
NEW YORK, March 16, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, announces today that President and CEO Michael Feldschuh will...
Daxor to Present at the Inaugural H.C. Wainwright BioConnect 2021 Conference
January 08, 2021 08:30 ET
|
Daxor Corporation
NEW YORK, Jan. 08, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology (organized as an investment company with fully-owned...
New Research Shows Daxor’s BVA-100® Blood Test Provides Unique Benefit in Detecting Anemia and Heart Failure Risk, Presented at the Heart Failure Society of America Meeting 2020
October 06, 2020 08:30 ET
|
Daxor Corporation
NEW YORK, Oct. 06, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
New Data Released from the Mayo Clinic Utilizing Daxor’s BVA-100® Test Highlights Value of Daxor’s Diagnostic at the Heart Failure Society of America Virtual Annual Scientific Meeting 2020
October 02, 2020 08:30 ET
|
Daxor Corporation
NEW YORK, Oct. 02, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
Daxor to Present at the Inaugural Sepsis Alliance Summit
September 15, 2020 08:30 ET
|
Daxor Corporation
NEW YORK, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
Daxor Corporation to Present at the LD 500 Virtual Investor Conference
August 31, 2020 08:30 ET
|
Daxor Corporation
NEW YORK, Aug. 31, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
Daxor Awarded $1.1 Million Contract from United States Department of Defense (DOD) for Rapid Portable Blood Volume Analyzer
April 23, 2020 08:30 ET
|
Daxor Corporation
New York, April 23, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
Daxor Corporation’s BVA-100® Test Used to Guide Treatment In COVID-19 Patient
March 20, 2020 08:00 ET
|
Daxor Corporation
New Clinical Protocol for Volume-Guided Therapy Helps Combat Coronavirus NEW YORK, March 20, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative...
Daxor Corporation Contracted to Adapt Its Blood Volume Analyzer Technology for U.S. Air Force Needs
March 09, 2020 08:30 ET
|
Daxor Corporation
NEW YORK, March 09, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
Daxor Corporation Announces Closing of $2.0 Million Registered Direct Offering Priced At-The-Market
March 06, 2020 08:00 ET
|
Daxor Corporation
NEW YORK, March 06, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE American: DXR) (“Daxor” or the “Company”), an investment company with innovative medical instrumentation and biotechnology...